Impact of Baduanjin exercise combined with rational emotive behavior therapy on sleep and mood in patients with poststroke depression: A randomized controlled trial
Yihan Liu,Chen Chen,Hanbin Du,Mengzhou Xue,Ning Zhu
DOI: https://doi.org/10.1097/md.0000000000038180
IF: 1.6
2024-05-11
Medicine
Abstract:Stroke is a common cerebrovascular disease with a high disability and case fatality rate, ranking as the second leading cause of death worldwide. With the acceleration of aging, the incidence rate of stroke is rising. [ 1 ] Poststroke depression (PSD) is one of the most common complications after stroke. About one-third of patients will have PSD in different periods after stroke, mainly manifested as depression, anxiety, sleep disorders, loss of interest, memory loss, difficulty concentrating, and other symptoms. [ 2 ] PSD hinders patients' rehabilitation process and functional recovery, diminishes their quality of life, and increases their disability and mortality rates. [ 3 ] Currently, the primary treatment method for PSD are antidepressants, but they have a slow onset. Some patients may not experience immediate mood improvement during the early stage of drugs, resulting in decreased treatment compliance, recurrent illness, and the delay of the best period of rehabilitation treatment. [ 4 ] Studies have confirmed that rational emotive behavior therapy (REBT) can improve the mood and sleep of PSD patients, but the treatment is mainly based on group therapy, which is difficult to achieve individualized precise treatment, and the cost is high, which is not conducive to the later family rehabilitation. In this study, based on the first-line antidepressant escitalopram, the method of combining traditional Chinese and Western medicine was used to combine REBT and traditional Baduanjin training to observe its effect on sleep, mood and serum BDNF, 5-HT and IL-6 levels in PSD patients. In order to develop a more individualized, reasonable, safe, and effective treatment plan for PSD patients, and provide clinical basis for the short-term and long-term prognosis of PSD patients.
medicine, general & internal